Med Care. 2011 Sep;49(9):834-41. doi: 10.1097/MLR.0b013e3182162afb.

Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007.

Briesacher BA, Zhao Y, Madden JM, Zhang F, Adams AS, Tjia J, Ross-Degnan D, Gurwitz JH, Soumerai SB.

Source

Division of Geriatric Medicine and Meyers Primary Care Institute, University of Massachusetts Medical School and Meyers Primary Care, Worcester, Boston, MA, USA. Becky.Briesacher@umassmed.edu

Abstract

CONTEXT:

The full effect of Medicare Part D, after the initial policy transition period and across the United States Medicare population, remains unclear.

OBJECTIVE:

To estimate nationally representative changes in prescription drug use and out-of-pocket drug costs 2 years after implementation of Part D.

DESIGN, SETTING, AND PARTICIPANTS:

We examined study outcomes over 8 years (2000 to 2007) and estimated changes after Part D, accounting for earlier trends. Our analyses used the community-dwelling sample of the Medicare Current Beneficiary Survey (unweighted unique n=38,798). Actual post-Part D outcomes were compared with projected values using 2000 to 2005 data. Subgroup analyses and standardization weights were used to address population-level shifts over time in health status and demographic characteristics.

MAIN OUTCOME MEASURES:

Annual prescription drug fills and out-of-pocket drug costs.

RESULTS:

We observed significant average per person increases of 1.8 prescription fills [95% confidence interval (CI), 1.1-2.5] in 2006 and 3.4 prescription fills (95% CI, 2.7-4.1) in 2007 above pre-Part D increases of 0.9 prescription fills per year. Average out-of-pocket drug costs decreased significantly by $143 (95% CI, -182.5--103.1) in 2006 and $148 (95% CI, -181.2--114.1) in 2007 above average pre-Part D increases of $12 per year. Prescription fills did not change for beneficiaries with fair to poor health until 2007 when large increases occurred (increases of 3.7 to 11.0 fills above pre-Part D trends). Significant reductions in OOP drug costs occurred in 2006 and persisted into 2007 across all groups except for sick and poor beneficiaries without Medicaid.

CONCLUSIONS:

After the transition year of 2006, the impact of Part D seemed larger and more consistent across the Medicare population. Of note, sick and poor beneficiaries experienced significant improvements in prescription drug use in 2007.